↓ Skip to main content

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Published in
Frontiers in Cardiovascular Medicine, September 2022
DOI 10.3389/fcvm.2022.1010693
Pubmed ID
Authors

Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, Donato Cappetta, Konrad Urbanek, Antonella De Angelis, Lucia Scisciola, Irene Di Meo, Maria Giuseppa Sullo, Concetta Rafaniello, Liberata Sportiello

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 8%
Student > Postgraduate 4 8%
Student > Bachelor 3 6%
Student > Master 3 6%
Student > Doctoral Student 2 4%
Other 6 12%
Unknown 27 55%
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Unspecified 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Economics, Econometrics and Finance 1 2%
Unknown 27 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2022.
All research outputs
#15,646,171
of 23,257,423 outputs
Outputs from Frontiers in Cardiovascular Medicine
#2,697
of 7,153 outputs
Outputs of similar age
#238,711
of 438,379 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#328
of 1,036 outputs
Altmetric has tracked 23,257,423 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,153 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,379 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,036 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.